Month: <span>November 2022</span>

Home / 2022 / November
New drug can successfully treat patients typically resistant to high blood pressure treatment
Post

New drug can successfully treat patients typically resistant to high blood pressure treatment

by Queen Mary, University of London Credit: Pixabay/CC0 Public Domain A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led jointly by a Queen Mary University of London researcher...

Hormone discovery could predict long-term health of men
Post

Hormone discovery could predict long-term health of men

by University of Nottingham Credit: CC0 Public Domain Researchers have discovered the vital role of a hormone, which develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life. Scientists from the University of Nottingham have discovered that the novel insulin-like peptide hormone, called INSL3, is...

Investigators shed new light on brain activity related to dissociative symptoms
Post

Investigators shed new light on brain activity related to dissociative symptoms

by McLean Hospital Triple network model of pathological dissociation. Credit: Neuropsychopharmacology (2022). DOI: 10.1038/s41386-022-01468-1 Trauma can cause dissociative symptoms—such as having an out-of-body experience, or feeling emotionally numb—that may help an individual cope in the short term but can have negative impacts if the symptoms persist for a long period of time. In a new study recently...

Post

FIRST EVER HUMANS INJECTED WITH SYNTHETIC, LAB-GROWN BLOOD

A team of researchers in the UK have injected lab-grown blood into humans for the first time, the BBC reports, in a demonstration of potentially game-changing medical tech that could end scarcity of rare blood types. The rarest blood types go far beyond the more conventional blood type groups, such as A, B, AB, and O. Some,...

Post

Diuretic Agents Equal to Prevent CV Events in Hypertension: DCP

Sue Hughes November 05, 2022 There was no difference in major cardiovascular outcomes with the use of two different diuretics — chlorthalidone or hydrochlorothiazide — in the treatment of hypertension in a new large randomized real-world study. The Diuretic Comparison Project (DCP), which was conducted in more than 13,500 U.S. veterans age 65 years or...

A brain stimulator powered by breath instead of batteries
Post

A brain stimulator powered by breath instead of batteries

by Kim Krieger, University of Connecticut UConn researchers have developed a way of charging deep brain stimulators that don’t require the battery power that’s currently standard. Credit: University of Connecticut Implantable deep brain stimulators can help many people with neurological and psychiatric disease when traditional treatments fail. But surgery every time the batteries need to...

Researchers identify protein linked to heart failure in chemo patients
Post

Researchers identify protein linked to heart failure in chemo patients

by University of Manitoba Credit: CC0 Public Domain A team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called TRAF2 that stops functioning in cancer patients taking the chemotherapy drug doxorubicin, which can result in heart failure. “The finding could lead to new...

Post

Ask a Doctor: What’s the best way to get rid of blackheads?

Advice by Jenna C. Lester, MD November 7, 2022 at 5:58 a.m. ES Jenna C. Lester is a dermatologist and the director of the Skin of Color Program at the University of California at San Francisco. Q: I have blackheads on my nose, chin and chest. Should I squeeze them? Does applying a moisturizer make...

Improved cystic fibrosis treatment is Science Breakthrough of the Year
Post

Improved cystic fibrosis treatment is Science Breakthrough of the Year

CHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN IMAGE: PROF. DR. MARCUS MALL © CHARITÉ | WIEBKE PEITZ CREDIT: © CHARITÉ | WIEBKE PEITZ The Falling Walls Foundation has awarded Prof. Dr. Marcus Mall of Charité – Universitätsmedizin Berlin the title Science Breakthrough of the Year 2022 in Life Sciences for a new treatment approach to cystic fibrosis. The...

Post

Sugar molecules as a target in cancer therapy

UNIVERSITY OF BASEL Cancer cells use sugar molecules on their surface to disable attacks by the body’s immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized. The immune system is actually extremely well equipped to get rid of abnormal cells. As a safety mechanism, special features are...